Sphera Funds Management Ltd. Point Biopharma Global Inc. Transaction History

Sphera Funds Management Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$5.72 - $9.78 $573,144 - $979,955	-100,200 Reduced 9.52%	952,642 $6.94 Million
Q3 2022 Nov 14, 2022	BUY	$7.24 - $10.31 $7.62 Million - $10.9 Million	1,052,842 New	1,052,842 $8.14 Million
Q1 2022 May 16, 2022	SELL	$5.46 - $8.13 $3.24 Million - $4.82 Million	-592,592 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.83 - $9.75 $708,068 - $1.43 Million	-146,598 Reduced 19.83%	592,592 $3.32 Million
Q3 2021 Nov 15, 2021	BUY	$7.42 - $11.26 $5.48 Million - $8.32 Million	739,190 New	739,190 $5.68 Million

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.